CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


07-February-2012
Introducing the latest internal standard from Cerilliant - Lisdexamfetamine-D4dimesylate.

Lisdexamfetamine-D4 dimesylate L-028
100 ug/mL (as free base) in Methanol

A certified solution standard suitable for quantitation of lisdexamfetamine in urine or other biological samples by GC/MS or LC/MS in clinical toxicology testing, forensic analysis, urine drug testing, or pharmaceutical research. Lisdexamfetamine, a psychostimulant prodrug of dextroamphetamine, is marketed as the drug Vyvanse® for treatment of attention deficit hyperactivity disorder (ADHD) in adults and children six to twelve years of age.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn